KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Evolent Health (EVH) Tax Provisions (2016 - 2026)

Evolent Health has reported Tax Provisions over the past 11 years, most recently at -$1.7 million for Q4 2025.

  • For Q4 2025, Tax Provisions fell 50.09% year-over-year to -$1.7 million; the TTM value through Dec 2025 reached -$75000.0, up 94.47%, while the annual FY2025 figure was -$100000.0, 92.86% up from the prior year.
  • Tax Provisions for Q4 2025 was -$1.7 million at Evolent Health, down from $906000.0 in the prior quarter.
  • Over five years, Tax Provisions peaked at $1.5 million in Q1 2025 and troughed at -$68.2 million in Q1 2023.
  • A 5-year average of -$6.7 million and a median of -$337000.0 in 2021 define the central range for Tax Provisions.
  • On a YoY basis, Tax Provisions climbed as much as 351.83% in 2022 and fell as far as 19551.28% in 2022.
  • Year by year, Tax Provisions stood at -$436000.0 in 2021, then surged by 351.83% to $1.1 million in 2022, then tumbled by 1434.79% to -$14.7 million in 2023, then skyrocketed by 92.49% to -$1.1 million in 2024, then tumbled by 50.09% to -$1.7 million in 2025.
  • Business Quant data shows Tax Provisions for EVH at -$1.7 million in Q4 2025, $906000.0 in Q3 2025, and -$800000.0 in Q2 2025.